期刊文献+

壮医药线点灸对类风湿关节炎血清肿瘤坏死因子α及白细胞介素1β的影响 被引量:24

Influence of Medicated Thread Moxibustion of Zhuang Medicine on Tumor Necrosis Factor Alpha and Interleukin-1 Beta in Rheumatoid Arthritis( RA) Serum
原文传递
导出
摘要 目的:观察壮医药线点灸治疗对类风湿关节炎(RA)血清肿瘤坏死因子α及白细胞介素1β的影响,探讨其治疗机制。方法:选取活动性类风湿关节炎90例,随机分为药线治疗组30例,空白线灸组30例,西药对照组30例,药线治疗组和空白线灸组分别采用壮医药线、空白苎麻线点灸,同时配合西药治疗,采用ELISA法检测治疗前后3组患者的血清TNF-α和IL-1β。结果:药线治疗组治疗后与治疗前比较TNF-α、IL-1β有显著性差异(P<0.01),药线治疗组治疗后TNF-α、IL-1β较空白线灸组和西药对照组治疗后也有明显降低(P<0.05)。结论:壮医药线点灸治疗可降低RA患者的血清TNF-α、IL-1β水平,这是其可能的治疗机制。 Objective:To observe the intluence of the medicated thread moxibustion of Zhuang medicine on tumor necrosis factor alpha and interleukin- 1 beta in rheumatoid arthritis (RA) serum,exploring the treatment mechanism. Methods:90 eases of active rheumatoid arthritis were randomly divided into medicated thread treatment group, blank thread moxibustion group and western medicine eontrol group,30 cases for each group. The medicated thread treatment group and blank thread moxibustion group respectively used the medicated thread of Zhuang medieine and ramie line to moxibustion,at the same time cooperated with western medicine treatment in each group. ELISA method was used to detect se rum TNF - α and IL - 1 β in the three groups before and after treatment. Results : TNF - α and IL - 1β in medicated thread treatment group had a significant difference before and after treatment ( P 〈 0.01 ). Compared with blank thread moxibustion group and western medicine control group,TNF - α and IL - 1β in medicated thread treatment group reduced significantly (P 〈 0. 05 ). Conclusions : Treatment of the medicated thread moxibustion of Zhuang medicine can reduce the levels of TNF - α and IL - 1β in RA patients serum, and this is the possible mechanism of the treatment.
机构地区 柳州市中医院
出处 《中华中医药学刊》 CAS 2014年第2期332-334,共3页 Chinese Archives of Traditional Chinese Medicine
基金 广西自然科学基金面上项目(2010GXNSFA013258) 柳州市科技局科技攻关项目(2009021519)
关键词 壮医药线点灸 类风湿关节炎 肿瘤坏死因子Α 白细胞介素1Β medicated thread moxibustion of Zhuang medicine rheumatoid arthritis tumor necrosis factor alpha Interleukin - 1 beta
  • 相关文献

参考文献7

二级参考文献36

  • 1谢永欣,苏文芳,郑振光.贫血、血小板升高在评定类风湿关节炎病情中的作用[J].华北煤炭医学院学报,2007,9(1):48-49. 被引量:17
  • 2黄瑾明.壮医药线点灸疗法[M].南宁:广西人民出版社,1986.1.
  • 3田从豁.当代中国针灸临证精要[M].天津科学技术出版社,1987.59.
  • 4Schiff MH, Whehon A. Renal toxicity associated with disease modifying antirheumatic drugs used for the treatmeut of rheumatoid arthiritis [ J]. Semiu Arthritis Rheum,2000,30 : 196 - 208.
  • 5Amett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association1987 revised criteria for the classification of rheumatoid arthritis[ J ]. Arthritis Rheum, 1988,31:315 - 324.
  • 6Prevoo ML,van Gestel AM,vanl Hof MA,et al. Remission in a prospective study of patients with rheumatoid arthritis : American Rheumatism Association preliminary remission criteria in relation to the disease activity score [ J ]. Br J Rheumatol, 1996,35 : 1101 - 1105.
  • 7久我芳昭.臨床評価法ACRとEULARの改善基準.medical practice,2002,19:1153-1155.
  • 8Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis [ J ]. N Eegl J Med, 1994,330 : 1368 - 1375.
  • 9Bensen WG, Bensen W, Adachi JD. Back to the future : the pyramids of rheumatoid arthritis[ J]. J Rheumatol, 1997,24 : 1023 - 1027.
  • 10Fries JF,Wallimas CA,Morfeld D,et al. Reduction in long term disability in patients with rheumatoid arthritis by disease-modifying antirheumatie drug-based treatment strategies [ J ]. Arthritis Rheum, 1996,39:616 - 622.

共引文献75

同被引文献425

引证文献24

二级引证文献140

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部